Celularity Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Celularity Inc. (CELU) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$314.49 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-08-19
- Celularity Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$28.44K, a 113.43% decline year-over-year.
- Celularity Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$286.04K.
- Celularity Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was -$139.80K.
- Celularity Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was -$262.20K.
- Celularity Inc. cash and cash equivalents, period increase (decrease) for fiscal 2020 was -$602.31K, a 167.50% decline from fiscal 2019.
- Celularity Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $892.30K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 1 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 4 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2021-06-30 | -$28.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$314.49K 10-Q · filed 2021-08-19 | -$454.29K derived: sum of 3 quarters · filed 2021-08-19 | -$716.49K derived: sum of 4 quarters · filed 2021-08-19 | ||
| 2021-03-31 | -$286.04K 10-Q · filed 2021-05-24 | -$425.84K derived: sum of 2 quarters · filed 2021-05-24 | -$688.05K derived: sum of 3 quarters · filed 2021-05-24 | -$476.28K derived: sum of 4 quarters · filed 2021-08-19 | ||
| 2020-12-31 | -$139.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$402.00K derived: sum of 2 quarters · filed 2021-05-24 | -$190.23K derived: sum of 3 quarters · filed 2021-08-19 | -$602.31K 10-K/A · filed 2021-05-24 | ||
| 2020-09-30 | -$262.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$50.43K derived: sum of 2 quarters · filed 2021-08-19 | -$462.51K 10-Q · filed 2020-11-16 | -$570.31K derived: sum of 4 quarters · filed 2021-08-19 | ||
| 2020-06-30 | $211.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$200.31K 10-Q · filed 2021-08-19 | -$308.11K derived: sum of 3 quarters · filed 2021-08-19 | -$452.33K derived: sum of 4 quarters · filed 2021-08-19 | ||
| 2020-03-31 | -$412.08K 10-Q · filed 2021-05-24 | -$519.88K derived: sum of 2 quarters · filed 2021-05-24 | -$664.10K derived: sum of 3 quarters · filed 2021-05-24 | $486.05K derived: sum of 4 quarters · filed 2021-05-24 | ||
| 2019-12-31 | -$107.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$252.02K derived: sum of 2 quarters · filed 2021-05-24 | $898.13K derived: sum of 3 quarters · filed 2021-05-24 | $892.30K 10-K/A · filed 2021-05-24 | ||
| 2019-09-30 | -$144.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.01M derived: sum of 2 quarters · filed 2020-11-16 | $1.00M 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.14M 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | -$5.83K 10-Q · filed 2020-05-15 | |||||
| 2018-12-31 | $24.71K 10-K · filed 2020-03-24 | |||||
| 2018-09-30 | $9.46K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |